Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
about
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies.Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens.Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
P2860
Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@en
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@nl
type
label
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@en
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@nl
prefLabel
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@en
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@nl
P2093
P2860
P356
P1476
Favipiravir Pharmacokinetics i ...... of Hemorrhagic Fever Viruses.
@en
P2093
Anne-Marie Taburet
France Mentré
Frédéric Jacquot
Hervé Raoul
Koichi Yamada
Lisa Oestereich
Takumi Kadota
Thi Huyen Tram Nguyen
Vincent Madelain
P2860
P356
10.1128/AAC.01305-16
P407
P577
2016-10-10T00:00:00Z